Labcorp (LH) Stock Forecast & Price Target

$266.07 +6.11 (+2.35%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$265.83 -0.24 (-0.09%)

As of 08/8/2025 04:32 PM Eastern

Labcorp - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
1

Hold
3

Buy
9

Based on 13 Wall Street analysts who have issued ratings for Labcorp in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 1 has given a sell rating, 3 have given a hold rating, and 9 have given a buy rating for LH.

Consensus Price Target

$289.58
8.84% Upside

According to the 13 analysts' twelve-month price targets for Labcorp, the average price target is $289.58. The highest price target for LH is $310.00, while the lowest price target for LH is $260.00. The average price target represents a forecasted upside of 8.84% from the current price of $266.07.

Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Labcorp and its competitors.

LH Analyst Ratings Over Time

Type	Current Forecast 8/9/24 to 8/9/25	1 Month Ago 7/10/24 to 7/10/25	3 Months Ago 5/11/24 to 5/11/25	1 Year Ago 8/10/23 to 8/9/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$289.58	$276.38	$269.38	$249.15
Forecasted Upside	8.84% Upside	9.17% Upside	9.61% Upside	10.02% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Labcorp Stock vs. The Competition

Type	Labcorp	Medical Companies	S&P 500
Consensus Rating Score	2.62	2.81	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	8.84% Upside	27,881.34% Upside	13.84% Upside
News Sentiment Rating	Positive News See Recent LH News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/25/2025	UBS Group 4 of 5 stars	Kevin Caliendo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$282.00 ➝ $305.00	+15.23%
7/25/2025	Truist Financial 3 of 5 stars	David MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$290.00 ➝ $310.00	+17.12%
7/25/2025	Evercore ISI 3 of 5 stars	Elizabeth Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$285.00 ➝ $300.00	+12.22%
7/25/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ricky Goldwasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$283.00 ➝ $306.00	+14.43%
7/25/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$290.00 ➝ $302.00	+12.93%
7/10/2025	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/10/2025	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$260.00	+0.21%
6/25/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Cautious ➝ Cautious
5/6/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$260.00 ➝ $280.00	+13.84%
4/2/2025	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$276.00	+18.64%
Get the Latest News and Ratings for LH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Labcorp and its competitors with MarketBeat's FREE daily newsletter.
3/4/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ralph Giacobbe Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$250.00 ➝ $300.00	+18.11%
2/6/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tycho Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$275.00 ➝ $290.00	+17.25%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$262.00 ➝ $271.00	+16.67%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$220.00 ➝ $230.00	-2.35%
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$261.00 ➝ $243.00	+25.49%
3/25/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$250.00	+17.23%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$260.00	+18.63%
10/31/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$257.00 ➝ $230.00	+16.07%
8/14/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$290.00 ➝ $270.00	+23.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:13 PM ET.

Should I Buy Labcorp Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, August 8, 2025. Please send any questions or comments about these Labcorp pros and cons to contact@marketbeat.com.

Labcorp
Bull Case

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

The current stock price is around $229.89, reflecting a strong market position and potential for growth.
Institutional ownership is high at approximately 96.69%, indicating confidence from large investors in the company's future performance.
The company has shown a positive fifty-two week performance, suggesting resilience and potential for continued growth.
With a relatively low short percentage of float at about 1.98%, there is less risk of a short squeeze, which can lead to price volatility.
The average daily trading volume is substantial, providing liquidity and making it easier for investors to enter or exit positions.

Labcorp
Bear Case

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

There has been a slight decrease in shares shorted month-over-month, which may indicate a lack of bullish sentiment among some investors.
The days to cover is around 2.9, suggesting that it may take longer for short sellers to cover their positions, which could lead to price pressure.
Recent month-to-month changes in short interest show a minor decline, which could reflect uncertainty in the stock's future performance.
Despite a strong institutional ownership percentage, the overall market sentiment can still impact stock performance negatively.
With a float size of 83.67 million shares, any significant market movements could lead to increased volatility, posing risks for investors.

LH Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Labcorp is $289.58, with a high forecast of $310.00 and a low forecast of $260.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Labcorp in the last year. There is currently 1 sell rating, 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" LH shares.
: According to analysts, Labcorp's stock has a predicted upside of 8.84% based on their 12-month stock forecasts.
: Over the previous 90 days, Labcorp's stock had 2 downgrades by analysts.
: Labcorp has been rated by research analysts at Barclays, Evercore ISI, Hsbc Global Res, HSBC, Morgan Stanley, Robert W. Baird, Truist Financial, and UBS Group in the past 90 days.
: Analysts like Labcorp less than other "medical" companies. The consensus rating score for Labcorp is 2.62 while the average consensus rating score for "medical" companies is 2.81. Learn more on how LH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:LH) was last updated on 8/9/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Labcorp (LH) Stock Forecast & Price Target